Hygieia Research in Ann Arbor, MI is revolutionizing insulin therapy with their d-Nav Insulin Management Program, which aims to improve outcomes for individuals with type 2 diabetes. Their FDA-cleared technology provides personalized insulin dosing recommendations, making insulin therapy safer, more accurate, and more effective.
With a mission to rethink and reform how insulin is used, Hygieia's breakthrough technology has been life-changing for thousands of patients, offering a new standard of care in diabetes management. Patients like Gene, Hope, and Janis have experienced significant improvements in managing their blood sugar levels and overall well-being through the innovative d-Nav program.
Generated from the website